Skip to content

Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative

Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01593085
Acronym
DECAPAL
Enrollment
55
Registered
2012-05-07
Start date
2012-04-30
Completion date
2013-02-28
Last updated
2013-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

palliative cares, cancer, suicide risk

Brief summary

The investigators propose a study that aims to develop a methodology for assessing this risk and the psychological consequences of the malignancy in the palliative phase.

Interventions

BEHAVIORALinterview with a doctor for evaluating suicide risk

patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk) \--------------------------------------------------------------------------------

Sponsors

Centre Francois Baclesse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient (s) age (s) 18 or more * Patient (s) reach (s) of a cancer palliative stage * Patient (s) hospital (s) in the palliative care service * Patient (s) with cognitive function to an interrogation * Patient (s) having a physical condition for an interview lasting 45 minutes * Patient (s) that received clear information on the diagnosis and prognosis of their disease. * Free and informed consent signed

Exclusion criteria

* Patient (s) age (s) under 18 years * Patient (s) under supervision or unable to give informed consent * Patient (s) whose cognitive functions do not allow an examination.

Design outcomes

Primary

MeasureTime frameDescription
assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.at inclusion only, during hospitalization in palliative caresassessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.

Secondary

MeasureTime frameDescription
Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care serviceat inclusion only, during hospitalization in palliative caresEvaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service Questionnaires used are HADS Questionary, Scale HAMILTON, Scale BECK and Scale DUCHER
Assess the psychological impact of cancer pathology in patients in palliativeat inclusion only, during hospitalization in palliative caresAssess the psychological impact of cancer pathology in patients in palliative by evaluating depression score (with HADS HAMILTON, BECK, DUCHER scales)
Identify risk factors for suicide in this patient populationat inclusion only, during hospitalization in palliative caresIdentify risk factors for suicide in this patient population with evaluation of type of cancer, psychiatric history, family and social context, quality of life

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026